Lmr Partners LLP Summit Therapeutics Inc. Put Options Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2025 Aug 14, 2025	BUY	$16.64 - $36.7 $782,080 - $1.72 Million	47,000 Added 34.36%	183,800 $3.91 Million
Q1 2025 May 15, 2025	BUY	$16.65 - $23.76 $249,749 - $356,400	15,000 Added 12.32%	136,800 $2.64 Million
Q4 2024 Feb 14, 2025	BUY	$17.52 - $23.46 $381,936 - $511,428	21,800 Added 21.8%	121,800 $2.17 Million
Q3 2024 Nov 07, 2024	BUY	$6.89 - $31.93 $344,500 - $1.6 Million	50,000 Added 100.0%	100,000 $2.19 Million
Q2 2024 Aug 14, 2024	BUY	$2.39 - $10.92 $119,500 - $546,000	50,000 New	50,000 $390,000

266

90.9M

4.71M

3.17M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.8B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.